
AstraZeneca's Imfinzi receives EU approval, AFC Energy launches Joint venture with ICG
STOCKS TO WATCH Drugmaker AstraZeneca said on Friday that its Imfinzi asset has been approved in the EU as the first and only perioperative immunotherapy for muscle-invasive bladder cancer. AZN said the approval was based on Phase III trial results, which …